Plerixafor in Diabetic Wound Healing

NCT02790957 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

25

Enrollment

OTHER

Sponsor class

Stopped Safety reasons

Conditions

Diabetes
Wounds
Critical Limb Ischemia

Interventions

DRUG: Plerixafor
DRUG: Placebo

Sponsor

Gian Paolo Fadini

Collaborators

[object Object]